1. Home
  2. ADTX vs DRCT Comparison

ADTX vs DRCT Comparison

Compare ADTX & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aditxt Inc.

ADTX

Aditxt Inc.

HOLD

Current Price

$1.37

Market Cap

641.6K

Sector

Health Care

ML Signal

HOLD

Logo Direct Digital Holdings Inc.

DRCT

Direct Digital Holdings Inc.

HOLD

Current Price

$3.61

Market Cap

532.4K

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADTX
DRCT
Founded
2017
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
641.6K
532.4K
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ADTX
DRCT
Price
$1.37
$3.61
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$32.00
AVG Volume (30 Days)
1.8M
272.7K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
62.32
N/A
EPS
N/A
N/A
Revenue
$3,195.00
$34,694,000.00
Revenue This Year
N/A
$5.42
Revenue Next Year
N/A
$9.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.05
$0.04
52 Week High
$7.13
$7.21

Technical Indicators

Market Signals
Indicator
ADTX
DRCT
Relative Strength Index (RSI) 72.92 54.84
Support Level $0.80 $0.38
Resistance Level $1.84 $6.04
Average True Range (ATR) 0.10 0.83
MACD 0.19 -0.14
Stochastic Oscillator 70.65 12.14

Price Performance

Historical Comparison
ADTX
DRCT

About ADTX Aditxt Inc.

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

Share on Social Networks: